newsfilter
← Latest News
GlobeNewswire·

Molecular Templates, Inc. Provides Interim Update

Continued monotherapy activity in solid tumors with MT-6402 (PD-L1-targeting ETB) in checkpoint-experienced patients.Early pre-clinical and clinical data demonstrate the potential of MT-0169 (CD38-targeting ETB) in